英格兰高危与低危肾细胞癌患者手术等待时间分析
高危患者及时治疗率从83.7%降至64.8%,低危从71.3%降至47.6%,严重延误(>62天)从3.9%增至9.4%。高危患者优先于低危(73.6% vs 58.2%;调整RR 1.26,95%CI 1.22-1.31),但系统整体及时治疗率下降。
要点
- 高危RCC及时治疗率从2019年83.7%降至2023年64.8%,低危从71.3%降至47.6%。
- 严重延误(>62天)比例从3.9%增至9.4%,高龄和社会经济剥夺患者延误更长。
- 一旦超过及时治疗标准,每日手术概率急剧下降。
核心结论
- 高危RCC优先策略维持但未能阻止系统整体及时治疗率下降。
- 超过及时治疗标准的患者每日手术概率递减。
研究设计与样本
- 使用多级logistic回归估计及时治疗和严重延误概率。
主要发现
- 高危RCC及时治疗从83.7%(2019)降至64.8%(2023),低危从71.3%降至47.6%。
- 严重延误(>62天)从3.9%增至9.4%。
- 高危患者优先于低危(73.6% vs 58.2%;调整RR 1.26,95%CI 1.22-1.31)。
- 高龄和社会经济剥夺患者延误更长。
- 超过标准后每日手术概率急剧下降,高低危及时治疗率强相关(r=0.78)。
关键数值与推荐
- 及时治疗标准:从决定治疗起≤31天。
- 严重延误定义:>62天。
临床怎么用
- 需采用风险分层标准、专用手术容量并监测及时治疗标准之外的延误。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess to what extent hospitals meet the uniform English National Health Service 'timely' treatment standard, what happens after a breach, and determinants of delay for patients with high-risk renal cell carcinoma (RCC). PATIENT AND METHODS: Population-based study using linked data for 7030 patients with high-risk and 10 708 patients with low-risk RCC, 2019-2023. The probabilities of 'timely' treatment and prolonged delay (≤31 days or >62 days from decision-to-treat, respectively) were estimated using multilevel logistic regression. Daily treatment probabilities beyond 31 days were represented using smoothed hazard rates. RESULTS: For a typical patient with high-risk RCC, timely treatment declined from 83.7% (2019) to 64.8% (2023), with a corresponding decline in the low-risk group from 71.3% to 47.6%, while prolonged delays more than doubled, from 3.9% to 9.4%. Patients with high-risk RCC were prioritised over those with low-risk disease (73.6% vs 58.2%; adjusted risk ratio 1.26, 95% confidence interval 1.22-1.31). Older and more socioeconomically deprived patients experienced longer delays. Once the standard was breached, the daily probability of surgery declined sharply. Adjusted percentages of patients with high- and low-risk RCC treated within the standard were strongly correlated (r = 0.78). CONCLUSION: Prioritisation of patients with high-risk RCC was maintained throughout the study period but did not prevent a system-wide decline in timely treatment. Patients who breach the timely treatment standard face diminishing daily probabilities of surgery. Risk-stratified standards, ring-fenced surgical capacity, and monitoring beyond defined timely treatment standards are needed to safeguard patients against delays that have significant prognostic implications.
引用
- Varma R, Mayne E, Cuningham W, et al. Surgical waiting times in patients with high- and low-risk renal cell carcinoma in England. BJU Int. 2026. PMID: 42860314. doi:10.1111/bju.70490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。